] . (2012). The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1). Ophthalmology, 119, 2282-2289. presented at the 11/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22840421
. (2007). The Age-Related Eye Disease Study (AREDS) Simple Scale: The Relation of the AREDS Simple Scale for AMD to Long-Term Progression to Advanced AMD and Reduced Vision. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 06/05/2007, Fort Lauderdale, FL.
. (2005). The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 17. Arch Ophthalmol, 123, 1484-1498. presented at the 01/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16286610
. (2006). Cataract Phenotyping Using Serial Examinations in the Age-Related Eye Disease Study (AREDS). presented at the 2006.
. (2004). Clinical features and nature course of drusenoid pigment epithelial detachments in age-related macular degeneration. presented at the 2004.
. (2005). Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science, 308, 385-389. presented at the 04/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15761122
. (2006). Dietary Carotenoids and Cataract in the Age-Related Eye Disease Study. presented at the 2006.
. (2004). Dietary carotenoids and risk for age-related macular degeneration in the Age-Related Eye Disease Study. presented at the 2004.
. (2006). Dietary Lipid Intake and Vision Loss in the Age-Related Eye Disease Study. presented at the 2006.
. (2005). Dietary Zinc and Risk for Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 2005, Fort Lauderdale, FL.
. (2003). Dose Ranging Study of Lutein Supplementation in Persons over age 60. presented at the 2003.
. (2006). The Effect of Cataract Surgery on the Development of Neovascular Age-Related Macular Degeneration (AMD). presented at the 2006.
. (2004). Illustration of the AMD severity scale from the Age-Related Eye Disease Study. presented at the 2004.
. (2015). Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial. Invest Ophthalmol Vis Sci, 56, 330-338. presented at the 01/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25525171
. (2004). Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD. presented at the 2004.
. (2006). Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema. Am J Ophthalmol, 141, 193-194. presented at the 01/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16386999
. (2005). The Relationship of Omega(n)-3 Long-Chain Polyunsaturated Fatty Acid (LCPUFA) Intake and Regular Aspirin (ASA) Use with Prevalent Neovascular Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 01/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/
. (2005). Retinal Risk Factors and Progression to Geographic Atrophy in Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 21/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/
. (2005). A Simple Clinical Scale for Estimating the Risk of Age-Related Macular Degeneration Progression. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 01/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/
. (2013). Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial. Invest Ophthalmol Vis Sci, 54, 2941-2950. presented at the 04/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23548622